Hormone Optimization Part II: Thyroid & Adrenal Health in Cellular Medicine

August 14, 2025

Introduction

Thyroid and adrenal hormones are important regulators of metabolism, energy balance, stress adaptation, and normal function across many tissues. Thyroid hormones, primarily thyroxine (T4) and triiodothyronine (T3), help regulate metabolic rate, oxygen consumption, thermogenesis, gene expression, and mitochondrial activity. They also support normal function of the brain, heart, muscles, and other organ systems.

Adrenal hormones include cortisol, aldosterone, and catecholamines such as epinephrine (adrenaline). Cortisol helps coordinate the physiologic stress response and influences glucose availability, immune signaling, vascular tone, and blood-pressure regulation. Epinephrine supports rapid “fight-or-flight” responses, including changes in heart rate, blood flow, and fuel mobilization.

Disorders affecting thyroid or adrenal hormone signaling, including autoimmune thyroid disease, primary thyroid dysfunction, pituitary disorders, adrenal insufficiency, and cortisol excess, can affect energy metabolism, cardiovascular function, mood, sleep, and tissue-specific cellular processes. Nutrient deficiencies may also contribute to impaired thyroid-hormone production or metabolism; iodine is required to synthesize T4 and T3, while selenium-containing enzymes participate in thyroid-hormone activation and antioxidant defense.

At the cellular level, altered thyroid status can change mitochondrial respiration, oxidative phosphorylation, and metabolic demand. The relationship with oxidative stress is nuanced: hyperthyroidism is more consistently associated with increased reactive oxygen species and oxidative stress, whereas hypothyroidism may reduce both metabolic oxidant production and antioxidant activity.

Chronic psychological or physiologic stress may alter regulation of the hypothalamic–pituitary–adrenal (HPA) axis and can be associated with changes in cortisol signaling, inflammation, and oxidative stress.

This article explores the cellular physiology of the hypothalamic–pituitary–thyroid (HPT) and hypothalamic–pituitary–adrenal (HPA) axes, common endocrine disorders that affect these systems, and evidence-based nutritional considerations that support adequate hormone synthesis and metabolism.

Thyroid Physiology & Cellular Impact

  • The hypothalamic–pituitary–thyroid (HPT) axis regulates thyroid-hormone production and release through a negative-feedback system. Thyrotropin-releasing hormone (TRH) from the hypothalamus stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH), which in turn promotes thyroid synthesis and secretion of thyroxine (T4) and triiodothyronine (T3). In peripheral tissues, deiodinase enzymes, primarily DIO1 and DIO2, convert T4 to the more biologically active T3, while DIO3 helps inactivate thyroid hormone.
  • T3 binds thyroid-hormone receptors in the cell nucleus and regulates transcription of genes involved in metabolism, thermogenesis, and mitochondrial function. Its cellular effects include:
    • Mitochondrial Biogenesis: Thyroid-hormone signaling can increase PGC-1alpha activity and expression in metabolically active tissues, supporting mitochondrial biogenesis, oxidative metabolism, and tissue-specific energy demand.
    • Protein and metabolic turnover: T3 influences expression of enzymes involved in carbohydrate, lipid, and oxidative metabolism, helping regulate protein turnover and overall energy use.
    • Thermogenesis & Lipid Metabolism: In brown adipose tissue, thyroid hormone supports thermogenesis in part through UCP1-dependent uncoupled respiration and can promote pathways involved in fatty-acid oxidation. UCP1 dissipates energy as heat.

With hypothyroidism, metabolic rate and mitochondrial oxidative capacity generally decline, while lipid abnormalities and cardiovascular risk can increase. Oxidative-stress findings are more nuanced: hypothyroidism has been associated with reduced antioxidant-enzyme activity and higher oxidative-damage markers in some studies, but thyroid hormone excess also raises oxidative stress through increased metabolic activity.

Adrenal Physiology & Stress Response

  • The hypothalamic–pituitary–adrenal (HPA) axis coordinates cortisol production in response to circadian signals and physical, emotional, or metabolic stress. Corticotropin-releasing hormone (CRH) from the hypothalamus stimulates adrenocorticotropic hormone (ACTH) release from the anterior pituitary; ACTH then stimulates the adrenal cortex to produce cortisol. ACTH also supports adrenal androgen production, including DHEA, although DHEA regulation is not exclusively determined by acute stress signaling. Cortisol then provides negative feedback to the hypothalamus and pituitary to help regulate the system.
  • Cortisol is the body’s principal glucocorticoid and has several important physiologic functions:
    • Supporting glucose availability: Cortisol increases hepatic gluconeogenesis and promotes the release of metabolic substrates, including amino acids and fatty acids, to help maintain circulating glucose during fasting and stress. Cortisol can promote lipolysis while also contributing to fat accumulation when exposure is chronically elevated.
    • Modulating Inflammation: Through glucocorticoid-receptor signaling, cortisol generally suppresses inflammatory pathways, including NF-kappa B–mediated gene transcription, helping limit production of pro-inflammatory cytokines and excessive immune activation.
    • Regulating cellular stress pathways: Glucocorticoids can influence autophagy, cell survival, and apoptosis, but these effects vary by cell type, tissue, dose, and duration of exposure. For example, glucocorticoids can trigger apoptosis in certain immune-cell populations while protecting other cells from programmed cell death.

Persistent disruption of normal cortisol rhythms or sustained cortisol excess can be associated with insulin resistance, central adiposity, dyslipidemia, hypertension, and higher cardiovascular risk. These changes may also adversely affect sleep, mood, and cognition.

Common Dysfunctions

  1. Hashimoto’s Thyroiditis: Hashimoto’s is an autoimmune condition in which immune-mediated inflammation progressively damages thyroid tissue. Antibodies to thyroid peroxidase (anti-TPO) and thyroglobulin are common markers of the disease, although they are not themselves the sole mechanism of thyroid-cell injury. Over time, this process can reduce thyroid-hormone production and lead to hypothyroidism; local inflammation and oxidative stress may contribute to thyroid-tissue damage.
  2. Subclinical Hypothyroidism: This condition is defined by an elevated TSH with a normal free T4 concentration; T3 is not required for diagnosis and may remain normal. Some people have no symptoms, while others may experience nonspecific concerns such as fatigue. It is associated with a greater likelihood of unfavorable lipid changes, particularly at higher TSH levels, though individual cardiovascular risk and the benefits of treatment vary.
  3. HPA Axis Dysregulation: Chronic physical or psychological stress can alter HPA-axis signaling and the daily pattern of cortisol secretion. Chronic stress exposure can also cause metabolic, immune and mitochondrial signaling changes as well. The response is variable, some individuals may have higher baseline cortisol or a flattened diurnal rhythm rather than uniformly “low cortisol output.”

Targeted Nutritional & Lifestyle Strategies

  • Micronutrients for Thyroid Support
    • Iodine: The recommended dietary allowance for nonpregnant adults is 150 mcg daily; requirements increase to 220 mcg in pregnancy and 290 mcg during lactation. The adult tolerable upper intake level is 1,100 mcg daily, but people with autoimmune thyroid disease or existing thyroid dysfunction may be more sensitive to excess iodine, so supplementation should be individualized rather than routine.
    • Selenium: The adult recommended daily allowance is 55 mcg. Avoid exceeding the adult upper limit of 400 mcg daily from food and supplements combined.
    • Zinc: Zinc is required for many enzymatic and regulatory processes, including normal thyroid-hormone metabolism. Daily supplementation of 25–30 mg can support thyroid hormone synthesis and conversion. Supplementation is most appropriate when dietary intake is inadequate or deficiency is confirmed; sustained higher-dose zinc can impair copper absorption and should be clinician-supervised.
    • Iron: Iron deficiency should be assessed with a complete blood count, ferritin, and clinical context before treatment. If ferritin <50ng/mL, iron supplementation can improve energy and help improve metabolic function.
  • Stress and Adrenal Support:
    • Vitamin C: Vitamin C is concentrated in adrenal tissue and is required for several enzymatic processes. Supplementing with 1g daily may be reasonable in selected individuals, but it should not substitute for evaluating persistent fatigue, sleep disruption, weight change, or suspected endocrine disease.
    • Magnesium: Supplemental magnesium may support sleep quality in some individuals, particularly when intake is low. A common practical range is 200–400 mg of elemental magnesium daily; dose selection should account for the specific formulation, gastrointestinal tolerance, kidney function, and medication interactions.
    • Pantothenic Acid (B5): Pantothenic acid is essential for coenzyme A production and normal energy metabolism. Supplementing 300mg/day may enhance adrenal hormone production and stress adaptation
    • Adaptogens: Certain studies have shown that Ashwagandha (300–600mg/day) and rhodiola (200–400mg/day) may modestly improve perceived stress or sleep.
  • Circadian and Stress Practices:
    • Morning outdoor light exposure, consistent sleep and wake times, regular physical activity, and stress-management practices can support circadian alignment and overall metabolic health. Time-restricted eating may be helpful for some people. (e.g. see [Intermittent Fasting & Calorie Restriction: Cellular Pathways to Longevity])
    • Meditation, slow breathing, yoga, and similar mind-body practices are supportive lifestyle tools that can reduce perceived stress and may improve sleep or autonomic measures in some people.

*All supplements should be individualized according to dietary intake, medical history, laboratory findings, medications, and pregnancy status. Evaluation by a qualified clinician is especially important for persistent symptoms or suspected thyroid or adrenal disease.

Precision Peptide & Hormonal Therapies

  • Thyroid and Pineal Peptides: Specific low-molecular-weight peptides (derived from thyroid and pineal glands) have shown promise in improving thyroid function, lowering antibody levels, and enhancing tissue repair. Typical regimens involve short courses (e.g., 4–8weeks) under medical supervision
  • DHEA-S Supplementation: DHEA is an adrenal androgen precursor that can convert into testosterone and estrogen in peripheral tissues. Supplementation with oral DHEA, typically 25–50 mg each morning, may be considered for selected premenopausal women with confirmed primary adrenal insufficiency who continue to experience low libido, depressive symptoms, or low energy despite optimized glucocorticoid and mineralocorticoid replacement.

Practical Protocol & Monitoring

  1. Baseline Testing:
    • Assess: TSH and Free T4 as first-line thyroid tests; add Total or Free T3 when hyperthyroidism is suspected or clinically indicated. Consider anti-TPO and anti-Tg antibodies when autoimmune thyroiditis is suspected, and TSI or TRAb when Graves’ disease is suspected. DHEA-S, ferritin, complete blood count, vitamin D, zinc, and hs-CRP may be considered when supported by symptoms, diet, medical history, or specific clinical concerns.
      • Thyroid Autoantibodies: Anti-TPO and anti-Tg antibodies can support a diagnosis of autoimmune thyroiditis, including Hashimoto’s thyroiditis, when interpreted with thyroid-function tests and clinical findings.
      • TSI and TRAb: TSI and TSH-receptor antibodies (TRAb) are useful markers when Graves’ disease is suspected. A positive result supports autoimmune hyperthyroidism and can help distinguish Graves’ disease from other causes of thyrotoxicosis.
  2. Phase 1 (Weeks 1–4):
    • Focus: Confirm the diagnosis, correct documented nutrient deficiencies, and establish supportive lifestyle practices such as consistent sleep and wake times, morning light exposure, adequate nutrition, physical activity, and stress-management strategies.
    • Micronutrient supplementation, including iodine, selenium, zinc, iron, or vitamin D, should be based on dietary assessment, laboratory findings, and individual risk factors. Avoid routine high-dose supplementation, particularly iodine and iron, because excess intake may worsen thyroid dysfunction or cause other adverse effects.
    • Adaptogens such as ashwagandha or rhodiola may be considered
  3. Phase 2 (Weeks 5–8):
    • Add or adjust: Peptide and hormonal interventions (e.g., DHEA-S 10–25mg daily for adrenal support, thyroid and pineal peptides if indicated); continue cofactors and adaptogens
      • Direct use of peptides and hormonal therapies should be done only under medical supervision
  4. Monitoring:
    • Repeat labs approximately 6-8 weeks after implementing thyroid treatment recommendations.
      • Labs: TSH, Free T4/T3, cortisol, DHEA-S, ferritin, zinc, vitamin D, hs-CRP
        • If autoimmune thyroid disease is suspected or being managed add anti-TPO, anti-Tg, TSI, or TRAb
    • Monitor symptoms, vital signs, medication adherence, and adverse effects alongside targeted laboratory testing.
      • Weekly tracking of energy, sleep, mood, palpitations, tremor, weight change, and blood pressure can be useful

Conclusion & Call to Action

Thyroid and adrenal conditions can affect energy, mood, metabolism, cardiovascular health, sleep, and day-to-day function, but meaningful improvement starts with an accurate diagnosis and an individualized care plan. Evidence-based care combines appropriate laboratory evaluation, targeted treatment when indicated, attention to nutrition and lifestyle, and ongoing monitoring to support both symptom improvement and safe hormone levels.

Rather than pursuing a one-size-fits-all “hormone optimization” protocol, work with a qualified clinician to identify the factors contributing to your symptoms and determine whether thyroid disease, adrenal insufficiency, nutrient deficiency, sleep disruption, medication effects, or another health condition may be involved.

Ready to harness your full potential? Book a consultation with Dr. Seeds to discuss a personalized, evidence-informed plan for thyroid and adrenal health.